ROYAL BANK OF CANADA - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$30,000
+200.0%
5,835
+194.1%
0.00%
Q2 2023$10,000
+400.0%
1,984
+693.6%
0.00%
Q1 2023$2,000
-33.3%
2500.0%0.00%
Q4 2022$3,000
+200.0%
250
-0.8%
0.00%
Q3 2022$1,0000.0%252
+0.8%
0.00%
Q2 2022$1,000
-88.9%
250
-82.4%
0.00%
Q1 2022$9,000
+125.0%
1,422
+181.6%
0.00%
Q4 2021$4,000
-77.8%
505
-87.4%
0.00%
Q1 2021$18,000
+800.0%
4,000
+1011.1%
0.00%
Q2 2019$2,0003600.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2022
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders